Insider Transactions in Q4 2024 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 25
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
242
-1.14%
|
$21,538
$89.0 P/Share
|
|
Oct 25
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
514
+2.36%
|
-
|
|
Oct 01
2024
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-1.96%
|
$166,000
$83.83 P/Share
|